Effects of the superior mesenteric artery approach versus the no-touch approach during pancreatoduodenectomy on the mobilization of circulating tumour cells and clusters in pancreatic cancer (CETUPANC): randomized clinical trial
BJS Open · 2024
DOI: 10.1093/bjsopen/zrae123 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift BJS Open, 2024. Verfasst von Javier Padillo-Ruiz und 26 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Virgen del Rocío University Hospital, IBIS, University of Seville, Seville, Spain. Hauptthemen laut MEDLINE: Pancreaticoduodenectomy, Pancreatic Neoplasms, Neoplastic Cells, Circulating, Mesenteric Artery, Superior. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Instituto de Salud Carlos III.
Themen: Mobilisation
Abstract (Originalsprache)
Background
Patients with pancreatic ductal adenocarcinoma present early postoperative systemic metastases, despite complete oncological resection. The aim of this study was to assess two pancreatoduodenectomy approaches with regard to intraoperative circulating tumour cells and cluster mobilization and their potential association with the development of distant metastasis.
Methods
Patients with periampullary tumours who underwent open pancreatoduodenectomy were randomly allocated to either the no-touch approach or the superior mesenteric artery approach. A total of four intraoperative portal vein samples (at the beginning of the intervention, after portal vein disconnection from the tumour, after tumour resection, and before abdominal closure) were collected to measure circulating tumour cells and cluster numbers. Primary outcomes were the intraoperative number of circulating tumour cells and cluster mobilization. Further, their potential impact on 3-year distant metastasis disease-free survival and overall survival was assessed.
Results
A total of 101 patients with periampullary tumours were randomized (51 in the superior mesenteric artery group and 50 in the no-touch group) and 63 patients with pancreatic ductal adenocarcinoma (34 in the superior mesenteric artery group and 29 in the no-touch group) were analysed. Circulating tumour cells and cluster mobilization were similar in both the no-touch group and the superior mesenteric artery group at all time points. There were no significant differences between surgical groups with regard to the median metastasis disease-free survival (12.4 (interquartile range 6.1–not reached) months in the superior mesenteric artery group and 18.1 (interquartile range 12.1–not reached) months in the no-touch group; P = 0.730). Patients with intraoperative cluster mobilization from the beginning to the end of surgery developed significantly more distant metastases within the first year after surgery (P = 0.023). Two intraoperative factors (the superior mesenteric artery approach (P = 0.025) and vein resection (P < 0.001)) were predictive factors for cluster mobilization.
Conclusion
Patients undergoing pancreatoduodenectomy using either the no-touch approach or the superior mesenteric artery approach had similar circulating tumour cells and cluster mobilization and similar overall survival and metastasis disease-free survival. A high intraoperative cluster dissemination during pancreatoduodenectomy was a predictive factor for early metastases in patients with pancreatic ductal adenocarcinoma. Registration number NCT03340844 (http://www.clinicaltrials.gov)—CETUPANC trial.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Surgery, Virgen del Rocío University Hospital, IBIS, University of Seville, Seville, Spain.
- Health and Sciences Research Centre, Health and Sciences Faculty, Anahuac University, Huixquilucan, Mexico.
- Department of Surgery, Badajoz University Hospital, University of Extremadura, Badajoz, Spain.
- Department of Surgery, University Hospital of Salamanca, Salamanca Biosanitary Institute, University of Salamanca, Salamanca, Spain.
- Department of Surgery, University Hospital October 12 in Madrid, Madrid, Spain.
- Department of Surgery, Terrassa Mutual University Hospital, Terrassa, Spain.
ORCID-Profile: Javier Padillo-Ruiz, Gerardo Blanco, Fabio Ausania, Jose Alamo
Förderung
- Instituto de Salud Carlos III
Zitieren
APA
Padillo-Ruiz, J., Fresno, C., Suarez, G., Blanco, G., Muñoz-Bellvis, L., Justo, I., García-Domingo, M. I., Ausania, F., Muñoz-Forner, E., Serrablo, A., Martin, E., Díez, L., Cepeda, C., Marin, L., Alamo, J., Bernal, C., Pereira, S., Calero, F., Tinoco, J., …, & Sabater, L. (2024). Effects of the superior mesenteric artery approach versus the no-touch approach during pancreatoduodenectomy on the mobilization of circulating tumour cells and clusters in pancreatic cancer (CETUPANC): randomized clinical trial. BJS Open. https://doi.org/10.1093/bjsopen/zrae123
Vancouver
Padillo-Ruiz J, Fresno C, Suarez G, Blanco G, Muñoz-Bellvis L, Justo I, et al. Effects of the superior mesenteric artery approach versus the no-touch approach during pancreatoduodenectomy on the mobilization of circulating tumour cells and clusters in pancreatic cancer (CETUPANC): randomized clinical trial. BJS Open. 2024. doi:10.1093/bjsopen/zrae123
BibTeX
@article{PadilloRuiz2024,
author = {Padillo-Ruiz, Javier and Fresno, Cristóbal and Suarez, Gonzalo and Blanco, Gerardo and Muñoz-Bellvis, Luis and Justo, Iago and García-Domingo, Maria I and Ausania, Fabio and Muñoz-Forner, Elena and Serrablo, Alejandro and Martin, Elena and Díez, Luis and Cepeda, Carmen and Marin, Luis and Alamo, Jose and Bernal, Carmen and Pereira, Sheila and Calero, Francisco and Tinoco, Jose and Paterna, Sandra and Cugat, Esteban and Fondevila, Constantino and Diego-Alonso, Elisa and López-Guerra, Diego and Gomez, Miguel and Denninghoff, Valeria and Sabater, Luis},
title = {Effects of the superior mesenteric artery approach versus the no-touch approach during pancreatoduodenectomy on the mobilization of circulating tumour cells and clusters in pancreatic cancer (CETUPANC): randomized clinical trial},
journal = {BJS Open},
year = {2024},
doi = {10.1093/bjsopen/zrae123}
}
EUVIMED